Journal Information
Vol. 109. Issue 4.
Pages 360 (May 2018)
Vol. 109. Issue 4.
Pages 360 (May 2018)
Images in Dermatology
DOI: 10.1016/j.adengl.2017.02.030
Full text access
Cutaneous Metastases From Adenocarcinoma of the Prostate
Metástasis cutáneas de adenocarcinoma de próstata
Visits
...
M.Á. Flores-Terrya,
Corresponding author
miguelterry85@hotmail.com

Corresponding author.
, R. Cruz-Conde de Booma, M. García-Arpaa, I.M. de Lara-Simónb
a Servicio de Dermatología, Hospital General Universitario de Ciudad Real, Ciudad Real, España
b Servicio de Anatomía Patológica, Hospital General Universitario de Ciudad Real, Ciudad Real, España
Article information
Full Text
Download PDF
Statistics
Figures (1)
Full Text

An 87-year-old man had been diagnosed with acinar adenocarcinoma of the prostate (Gleason score 9) following transurethral resection of the prostate 5 years earlier. He was started on combined hormonal therapy (goserelin and bicalutamide). Two years later, he showed clinical progression (prostate-specific antigen, 3.83-45ng/mL) and a lack of response to abiraterone. Bladder involvement was detected and the patient underwent multiple operations to relieve the obstructions in addition to adjuvant radiotherapy. The patient consulted for asymptomatic cutaneous lesions that had appeared in the previous 2 weeks. Physical examination showed clusters of indurated pink papules with a smooth surface that formed a mass around the base of the penis (Fig. 1A). One of the lesions was ulcerated and necrotic (Fig. 1B) and there were several smaller lesions on an erythematous-edematous plaque on the pubis. Biopsy was consistent with cutaneous metastasis from adenocarcinoma of the prostate. The bilateral inguinal lymph nodes were enlarged on palpation, and the computed tomography scan showed retroperitoneal, visceral, and bone involvement. The patient died 3 weeks later. Prostate cancer is the third most common cancer in men. Cutaneous metastases are rare in this setting, with an incidence of less than 1%, but they can be the first sign of extranodal disease. Prognosis is poor (mean survival of 7 months) and treatment is purely palliative.

Figure 1
(0.3MB).

Please cite this article as: Flores-Terry MÁ, Boom RC-Cd, García-Arpa M, de Lara-Simón IM. Metástasis cutáneas de adenocarcinoma de próstata. Actas Dermosifiliogr. 2018;109:360.

Copyright © 2017. Elsevier España, S.L.U. and AEDV
Idiomas
Actas Dermo-Sifiliográficas (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?